|
|
Dear Reader,
We are pleased to deliver your requested table of contents alert for Clinical and Translational Oncology. Volume 18 Number 10 is now available online.
|
|
|
In this issue
|
Signaling and molecular basis of bone marrow niche angiogenesis in leukemia
R. Shirzad, S. Shahrabi, A. Ahmadzadeh, K. R. Kampen, M. Shahjahani & N. Saki
|
|
|
Role of taxanes in advanced prostate cancer
J. Cassinello, J. Carballido Rodríguez & L. Antón Aparicio
|
|
|
Germline BRCA testing is moving from cancer risk assessment to a predictive biomarker for targeting cancer therapeutics
L. Moreno, C. Linossi, I. Esteban, N. Gadea, E. Carrasco, S. Bonache, S. Gutiérrez-Enríquez, C. Cruz, O. Díez & J. Balmaña
|
|
|
Gemcitabine versus FOLFIRINOX in patients with advanced pancreatic adenocarcinoma hENT1-positive: everything was not too bad back when everything seemed worse
A. Orlandi, M. A. Calegari, M. Martini, A. Cocomazzi, C. Bagalà, G. Indellicati, V. Zurlo, M. Basso, A. Cassano, L. M. Larocca & C. Barone
|
|
|
Research Article |
|
Ki-67 is a prognostic marker for hormone receptor positive tumors
M. E. Pérez-López, J. García-Gómez, M. T. Alves, A. Paradela, J. García-Mata & T. García-Caballero
|
|
|
Stereotactic body radiation therapy and intensity modulated radiation therapy induce different plasmatic cytokine changes in non-small cell lung cancer patients: a pilot study
M. Trovo, N. Giaj-Levra, C. Furlan, M. T. Bortolin, E. Muraro, J. Polesel, E. Minatel, R. Tedeschi, A. R. Filippi, F. Alongi & U. Ricardi
|
|
|
Influence of different treatment techniques and clinical factors over the intrafraction variation on lung stereotactic body radiotherapy
M. Rico, E. Martínez, S. Pellejero, B. Bermejo, P. Navarrete, M. Barrado, M. Campo, F. Mañeru, E. Villafranca & J. Aristu
|
|
|
Pro-gastrin-releasing peptide and neuron-specific enolase: useful predictors of response to chemotherapy and survival in patients with small cell lung cancer
Z. Huang, D. Xu, F. Zhang, Y. Ying & L. Song
|
|
|
The number of risk factors is the strongest predictor of prostate cancer mortality: multi-institutional outcomes of an extreme-risk prostate cancer cohort
A. Gomez-Iturriaga, Á. Cabeza, J. Pastor, J. Jove, M. Casaña, A. G. Caamaño, J. Mengual, I. Henríquez, J. Muñoz, A. Hervás & C. G.-S. Segundo
|
|
|
Long-term visual outcomes in intraocular retinoblastoma with eye preservation
A. Batra, N. Pushker, P. Venkatesh, T. Arora, R. Tewari & S. Bakhshi
|
|
|
Research Article |
|
Sensitive methods for screening of the MEK1 gene mutations in patients with central nervous system metastases of non-small cell lung cancer
M. Nicoś, P. Krawczyk, B. Jarosz, M. Sawicki, M. Michnar, T. Trojanowski & J. Milanowski
|
|
|
Clinical use of ipilimumab for metastatic melanoma in Spain: towards a more consistent approach
S. Martín-Algarra, L. de la Cruz-Merino, V. Soriano, J. L. Manzano & E. Espinosa
|
|
|
|
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου